Rigel Pharmaceuticals, Inc. (RIGL): Price and Financial Metrics
Rigel Pharmaceuticals, Inc. (RIGL)
Today's Latest Price: $3.48 USD
Updated Jan 27 9:13am
Add RIGL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
RIGL Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for RIGL is 2.07 -- better than 74.83% of US stocks.
- The ratio of debt to operating expenses for Rigel Pharmaceuticals Inc is higher than it is for about merely 22.92% of US stocks.
- As for revenue growth, note that RIGL's revenue has grown 29.15% over the past 12 months; that beats the revenue growth of 83.89% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Rigel Pharmaceuticals Inc, a group of peers worth examining would be MRIN, KOPN, MOSY, ATNX, and OIIM.
- RIGL's SEC filings can be seen here. And to visit Rigel Pharmaceuticals Inc's official web site, go to www.rigel.com.
RIGL Stock Price Chart Interactive Chart >
RIGL Price/Volume Stats
| Current price | $3.48 | 52-week high | $5.24 |
| Prev. close | $3.54 | 52-week low | $1.23 |
| Day low | $3.48 | Volume | 13,237 |
| Day high | $3.48 | Avg. volume | 2,320,279 |
| 50-day MA | $3.35 | Dividend yield | N/A |
| 200-day MA | $2.52 | Market Cap | 588.05M |
Rigel Pharmaceuticals, Inc. (RIGL) Company Bio
Rigel Pharmaceuticals, Inc. engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disorders. The company was founded in 1996 and is based in South San Francisco, California.
Loading social stream, please wait...